Antimitotic Agents: all 5,052 studies that test it

Page 14 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia SalvageCompletedNCT00890656Phase 2Results posted
• Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00888615Phase 2Results posted
• Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma SubtypesCompletedNCT00887809Phase 2Results posted
• Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast CancerCompletedNCT00887575Phase 1/2Results posted
• The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00887315Phase 2Results posted
• Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic MelanomaCompletedNCT00885534Phase 2Results posted
• A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial CancerTerminatedNCT00883116Phase 3Results posted
• A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic CancerCompletedNCT00882310Phase 2Results posted
• Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic LeukemiaTerminatedNCT00882206Phase 2Results posted
• A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast CancerCompletedNCT00879086Phase 2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell LymphomaCompletedNCT00878254Phase 2Results posted
• Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown PrimaryCompletedNCT00873119Phase 2Results posted
• S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00872989Phase 2Results posted
• TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or MedulloblastomaCompletedNCT00867568Phase 1Results posted
• Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast CancerCompletedNCT00866905Phase 2Results posted
• Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic LymphomaCompletedNCT00866749Phase 2Results posted
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant MelanomaCompletedNCT00864253Phase 3Results posted
• Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerTerminatedNCT00863512Phase 3Results posted
• Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate CancerTerminatedNCT00861471Phase 1/2Results posted
• Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck CancerCompletedNCT00851877Phase 1/2Results posted
• Treatment With Pazopanib for Neoadjuvant Breast CancerCompletedNCT00849472Phase 2Results posted
• Medical Treatment of "High-Risk" NeurofibromasCompletedNCT00846430Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast CancerCompletedNCT00846027Phase 2Results posted
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the PancreasCompletedNCT00844649Phase 3Results posted
• Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00842712Phase 2Results posted
• Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian OriginTerminatedNCT00840450Phase 2Results posted
• Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck CancerCompletedNCT00833261Phase 2Results posted
• E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)CompletedNCT00832819Phase 1Results posted
• Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence ScoresTerminatedNCT00832338Phase 2Results posted
• Phase I Combination Ixabepilone + CisplatinCompletedNCT00832117Phase 1Results posted
• Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLCCompletedNCT00828841Phase 2Results posted
• Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate CancerCompletedNCT00828308Phase 2Results posted
• Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast CancerCompletedNCT00825734Phase 1/2Results posted
• S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin LymphomaCompletedNCT00822120Phase 2Results posted
• Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerCompletedNCT00821964Phase 2Results posted
• Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast CancerCompletedNCT00821886Phase 2Results posted
• Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast CancerCompletedNCT00820872Phase 2Results posted
• Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194CompletedNCT00820170Phase 1/2Results posted
• A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)CompletedNCT00819585Phase 2Results posted
• Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid TumoursCompletedNCT00809133Phase 1Results posted
• Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial CancerStatus unknownNCT00807768Phase 3Results posted
• QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung CancerTerminatedNCT00807612Phase 1/2Results posted
• Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response AssessmentCompletedNCT00807573Phase 2Results posted
• LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung CancerCompletedNCT00805194Phase 3Results posted
• Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLCTerminatedNCT00801801Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain MetastasisCompletedNCT00800202Phase 2Results posted
• Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, DacarbazineCompletedNCT00796991Phase 1Results posted
• A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast CancerCompletedNCT00789581Phase 3Results posted
• Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate CancerTerminatedNCT00786682Phase 2Results posted
• Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerCompletedNCT00785291Phase 3Results posted
• Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITPCompletedNCT00774202Phase 2/3Results posted
• S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin LymphomaCompletedNCT00770224Phase 2Results posted
• Study Evaluating Safety And Tolerability, Solid TumorCompletedNCT00768469Phase 1Results posted
• Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast CancerTerminatedNCT00765765Phase 1/2Results posted
• Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal JunctionCompletedNCT00757172Phase 2Results posted
• Phase II Neoadjuvant in Inflammatory Breast CancerTerminatedNCT00756470Phase 2Results posted
• A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast CancerCompletedNCT00748553Phase 1/2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By SurgeryCompletedNCT00738361Phase 2Results posted
• Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ AdenocarcinomaCompletedNCT00737438Phase 2Results posted
• Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary SiteCompletedNCT00737243Phase 2Results posted
• Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck CancerCompletedNCT00736944Phase 2Results posted
• Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung CancerTerminatedNCT00735878Phase 1/2Results posted
• A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung CancerCompletedNCT00735696Phase 2Results posted
• Multimodality Phase II Study in Prostate CancerTerminatedNCT00734851Phase 2Results posted
• Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerCompletedNCT00733408Phase 2Results posted
• Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC PatientsCompletedNCT00730925Phase 2Results posted
• Sutent + Taxol for Advanced Esophageal CancerCompletedNCT00730353Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00729612Phase 2Results posted
• A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung CancerCompletedNCT00723957Phase 2Results posted
• Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast CancerCompletedNCT00723125Phase 2Results posted
• Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00721513Phase 2Results posted
• Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckCompletedNCT00720304Phase 2Results posted
• Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid TumorCompletedNCT00711243Phase 1/2Results posted
• Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBCCompletedNCT00709761Phase 2Results posted
• Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer SubjectsTerminatedNCT00709618Phase 2Results posted
• Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus CancerTerminatedNCT00707473Phase 2Results posted
• Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh SystemCompletedNCT00706095Phase 1Results posted
• Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast CancerCompletedNCT00706030Phase 1/2Results posted
• Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00705874Phase 1Results posted
• Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian CancerCompletedNCT00702299Phase 1Results posted
• Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine TherapyCompletedNCT00691054Phase 2Results posted
• Docetaxel in Node Positive Adjuvant Breast CancerCompletedNCT00688740Phase 3Results posted
• A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)CompletedNCT00687440Phase 2Results posted
• Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung CancerCompletedNCT00683904Phase 1Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast CancerCompletedNCT00675259Phase 2Results posted
• Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic LeukemiaCompletedNCT00671658Phase 2Results posted
• Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast CancerCompletedNCT00670982Phase 2Results posted
• Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell LymphomaCompletedNCT00670358Phase 1/2Results posted
• Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/LymphomaCompletedNCT00669877Phase 2Results posted
• Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate CancerCompletedNCT00669162Phase 1/2Results posted
• Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryTerminatedNCT00665457Phase 2Results posted
• Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx CancerCompletedNCT00665392Phase 2Results posted
• Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00664105Phase 2Results posted
• Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By SurgeryTerminatedNCT00662311Phase 1/2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00662129Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung CancerCompletedNCT00661778Phase 2Results posted
• A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerCompletedNCT00661609Phase 2Results posted
• S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00661193Phase 2Results posted
• A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary CancersCompletedNCT00660699Phase 2Results posted

← Antimitotic Agents overview